In this cross-sectional case-control study of 58 male individuals, cannabinoid 1 receptor availability was lower in male patients with first-episode psychosis who did not use cannabis, including in patients who were antipsychotic naive or antipsychotic free, and exploratory analyses indicated that greater reductions are associated with poor cognitive functioning and greater symptom severity. Here, CNR1 is linked to psychotic disorder.